baber/WOPTO huggingface dataset:
Patent CA-2519879-A1 (CA)
Inventor: BOEHM ROBERT
IPC: A63B69/36
Filed: 2003-06-14
Abstract: The invention relates to an aid (10) for facilitating learning how to play golf. This aid is attached to a golf club having a club head and shaft, and can be mounted on the club head or on the shaft of the golf club while being located in the vicinity of the club head. Said aid comprises a device (22) that redirects the image, which, starting from the device, can be viewed in the line of sight perpendicular to the leading edge of a striking surface of the club head, toward the head of a golf player who is using the aid. This device is fastened to the club by means of magnets.
Patent CA-2521703-A1 (CA)
Title: Gimbal system
Inventor: WESCOTT TIMOTHY A
IPC: F16M11/18
Filed: 2005-09-29
Abstract: A gimbal system. The gimbal system may include space-saving features configured to accommodate one or more payload components, thus increasing the payload capacity of the gimbal ball without necessarily increasing the outer dimensions of the gimbal ball. Alternatively, or in addition, the gimbal system may include a motor configured to move at least one gimbal relative to another gimbal about a first axis, with the motor peripherally mounted distal the axis.</SD OAB>
Patent CA-2528090-A1 (CA)
Inventor: BOMMER JERRY C
IPC: A61B5/055
Filed: 2004-06-04
Abstract: The present invention provides a class of porphyrins and metal chelated porphyrins for use as inhibitors of heme iron uptake. The porphyrin/metal chelated porphyrin molecules of the invention are tetra-positively charged porphyrins based on meso-tetra (4-pyridyl) porphines. Several such agents are shown herein to cause inhibition of iron uptake in vivo and in vitro. The invention further provides therapeutic compositions including the porphyrins and/or metalloporphyrins of the invention. In addition, methods of inhibition of heme iron uptake in vivo are taught, as well as methods of treatment of diseases characterized by iron-overload. These methods include the administration of a porphyrin or metalloporphyrin in a therapeutic composition of the invention to prevent uptake of heme iron, thus preventing replenishment of a patient's iron stores.
Patent CA-2528542-A1 (CA)
Inventor: KUTRYK EDWARD A
IPC: B07B1/28
Filed: 2005-12-01
Abstract: A pretensioned screen assembly for a vibratory separator includes a perforated plate for supporting screening material, with the perforated plate having downwardly extending L-shaped tabs. The tabs have a vertical portion that extends along and attaches to a side of a generally rectangular supporting frame. The tabs further have a horizontal portion that extends along a bottom of the frame. The tabs are attached at least to frame members that are most susceptible to high frequency vibratory forces. The plate is thereby more securely attached to the frame as compared to conventional perforated plates which are attached only to a top of the frame. Further the tabs structurally reinforce the frame members to which they are attached. Consequently, the screen assembly is more resistant to separation of the screen assembly components caused by vibration-induced flexing.
Patent CA-2529759-A1 (CA)
Inventor: ELLIS TAMIR M
IPC: G01N33/92
Filed: 2004-06-21
Abstract: Biomarkers that are diagnostic of type 1 diabetes, type 2 diabetes and/or diabetic disorder are identified. Detection of different biomarkers of the invention are also diagnostic of the degree of severity of type 1 diabetes, type 2 diabetes and/or diabetic disorder. An analysis includes the parameters of matching for BMI and Tanner stage. Receiver-operator characteristic (ROC) curves were established to assess association of the biomarkers with a disease.
Patent CA-2532443-A1 (CA)
Title: Tyrosine kinase inhibitors
Inventor: KIM ANNETTE S
IPC: C07D207/30
Filed: 2004-07-20
Abstract: The present invention relates to compounds that are capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases. The compounds of the instant invention possess a core structure that comprises a substituted pyrrole moiety. The present invention is also related to the pharmaceutically acceptable salts, hydrates and stereoisomers of these compounds.
Patent CA-2534924-A1 (CA)
Title: Novel metaxalone compositions
Inventor: BOSCH WILLIAM H
IPC: A61K31/421
Filed: 2004-07-26
Abstract: The present invention is directed to nanoparticulate compositions comprising metaxalone. The metaxalone particles of the composition have an effective average particle size of less than about 2 microns.
Patent CA-2535060-A1 (CA)
Inventor: BRYAN JONES W
IPC: A61K9/48
Filed: 2004-09-07
Abstract: The present invention is directed to the oral osmotic delivery of therapeutic compounds that have limited solubility in an aqueous environment due to inherent hydrophobicity or to saturation limitations in the core of the osmotic system. The present invention is suitable for the osmotic delivery of glipizide and other hydrophobic drugs, but runs the spectrum to other therapeutic agents with higher aqueous solubilities, yet having a solubility limitation in an osmotic dosage unit due to high drug load.
Patent CA-2535680-A1 (CA)
Inventor: PHILLIPS IAN M
IPC: A61K35/12
Filed: 2004-08-11
Abstract: Bone marrow-derived mesenchymal stem cells were transduced with a stimulus-responsive rAAV vector system that detects and responds to hypoxia in cardiac tissue. A first rAAV vector in the system contains a cardiac-specific promoter linked to a sequence encoding an oxygen-sensitive chimeric transactivator containing a GAL4 DNA binding domain, an oxygen-dependent degradation domain, and a p65 activation domain. A second rAAV vector contains a cardioprotective gene linked to a GAL4 UAS. The first rAAV vector expresses the chimeric transactivator specifically in the heart, and in response to hypoxia, the transactivator binds to the GAL4 upstream activating sequence (UAS) in the second rAAV vector. Binding of the transactivator to the UAS results in the expression of the cardioprotective gene. The rAAV vectors can be used to treat cells in a number of other disease states, including diabetes, cancer, stroke, and atherosclerosis. These approaches to stem cell-based gene therapy provide a novel strategy not only for treatment but for prevention of cell destruction.
Patent CA-2536511-A1 (CA)
Title: Allogenic/xenogenic implants and methods for augmenting or repairing intervertebral discs
Inventor: MCKAY WILLIAM F
IPC: A61L27/36
Filed: 2004-07-22
Abstract: Allogenic or xenogenic materials are used to provide intervertebral disc nucleus implants and/or annular plugs. The allogenic or xenogenic materials comprise natural disc annulus material, which may have a portion of the anterior longitudinal ligament attached. The tissue may be used "as is"  without an additional core or covering, or it may be used in combination with other materials. The material may be rolled, folded, layered and/or sutured, stapled, or glued to provide a solid plug of natural biological material. The implant may be provided as a dehydrated, substantially rod-shaped segment having a diameter less than the diameter of the hydrated material, and may have one or more ends of the dehydrated rod terminate with a further reduced diameter portion, preferably a point.
Patent CA-2540436-A1 (CA)
Title: Cheese products provided with a soft extruded cheese texture and fermented milk product taste and method for producing said cheese products
Inventor: VIAUD FLORENCE
IPC: A23C19/09
Filed: 2004-09-29
Abstract: Method for producing novel cheese products having a fibrous texture and a fresh and lactic taste by processing an initial raw material which includes a drawn-curd cheese having a firm and fibrous texture, adding a defined quantity of fermented milk product and processing the mixture.
Patent CA-2541001-A1 (CA)
Title: Isothiocyanate preservatives and methods of their use
Inventor: BUNKE PAUL RALPH
IPC: A23L3/3526
Filed: 2004-09-29
Abstract: A composition for preserving solid food products comprising a moisture-sensitive isothiocyanate compound and a hygroscopic carrier, wherein the composition is substantially free of sorbic acid, benzoic acid, and salts thereof. Also disclosed is a solid food product containing the aforementioned preservative composition and a method for preserving solid food products including the steps of adding a moisture-sensitive isothiocyanate to the solid food product and storing the resulting product at a reduced temperature.
Patent CA-2541026-A1 (CA)
Title: Strictly nonblocking multicast multi-stage networks
Inventor: KONDA VENKAT
IPC: H04Q1/00
Filed: 2003-09-06
Abstract: A three-stage network (Fig. 1A) is operated in strictly nonblocking manner i n accordance with the invention includes an input stage (101) having r 1 switches (IS) and n 1 inlet links (IL) for each of r 1 switches, an output stage (120) having r 2 switches (OS) and n 2 outlet links (OL) for each of r 2 switches. The network also has a middle stage (130) of m switches (MS), and each middle switch has at least one link connected to each input switch for a total of at least r 1 first internal links and at least one link connected t o each output switch for a total of at least r 2 second internal links, where m >= 2 * n 1 + n 2 - 1. In one embodiment, each multicast connection is set up through such a three-stage network by use of at most two switches in the middle stage.
Patent CA-2543472-A1 (CA)
Inventor: MARXER CORNEL
IPC: A61N1/00
Filed: 2004-10-27
Abstract: A bistable MEMS switch for use in selectively opening or closing electrical circuits included in an implantable medical device system is provided. The switch includes central movable beam having a movable contact; a suspension system for supporting the movable beam and generating a contact force; an actuator for displacing the beam upon application of an activation signal, and a fixed contact for interfacing the movable contact when the switch is in a closed state. The switch is fabricated from a Si/SiO2/Si wafer using photolithography, DRIE and sacrificial oxide etching followed by metalization of electrical contact points with a wear-resistant metal or alloy. An actuation layer may be fabricated from the silicon substrate layer of the wafer and the signal layer may be fabricated from the top silicon layer. The actuation layer and signal layer are thereby electrically decoupled and mechanically coupled by the intervening SiO2 layer.
Patent CA-2543753-A1 (CA)
Title: Method and system for accessing and managing virtual machines
Inventor: SABEAN JOHN
IPC: G06F9/46
Filed: 2004-10-26
Abstract: A Virtual Access Core (VAC) manages and controls access to virtual machines. A  Virtual Instruction Routine (VIR) protocol is used by all components of the system to pass instructions and information about a Virtual Session. The VAC  issues commands in the VIR protocol language causing virtual machines to start and stop. A VIR host that hosts virtual machines responds to VAC commands. Web clients access the system via links, which a web server uses to send access requests to the VAC. The VAC responds by searching through process memory and database tables for information about free slots on a plurality of VIR hosts grouped into a Host Array. When one or more free slots have been identified, the VAC issues VIR Protocol commands instructing one or more VIR Hosts to load and start specific virtual machines in Specific Slots. Each VIR Host looks up a set of firewall rules dynamically created, with instructions on how to isolate and create a Virtual Network for that client session providing privacy and non-interference between virtual machines in the Host Array. The VAC  passes instructions to a VNC Proxy enabling communication between the client session and the virtual machine. An example of use of the system is a Virtual Classroom where students are given access to a Virtual Network enabling them to perform practical exercises as an augmentation to their web based training.
Patent CA-2544090-A1 (CA)
Title: Stable driving scheme preventing the accumulative aging in active matrix displays
Inventor: NATHAN AROKIA
IPC: G09G3/3225
Filed: 2006-04-19
Abstract: Disclosed is a technique for controlling the aging of the pixels in light emitting displays.
Patent CA-2545260-A1 (CA)
Title: Compositions and methods for modulating c-rel-dependent cytokine production
Inventor: BARSOUM JAMES
IPC: G01N33/567
Filed: 2004-11-10
Abstract: The present invention is directed to compositions and methods for modulating c-Rel-dependent cytokine production without materially altering the level of expression of NF.kappa.B and/or the amount of I.kappa.B. The present invention is also directed to screening for modulators of c-Rel activity as determined by assaying for altered subcellular localization of c-Rel but where the level of expression of NF.kappa.B and/or the amount of I.kappa.B is materially unaltered.
Patent CA-2545916-A1 (CA)
Title: Apparatus method and medium for detecting payload anomaly using n-gram distribution of normal data
Inventor: STOLFO SALVATORE J
IPC: H04L29/06
Filed: 2004-11-12
Abstract: A method, apparatus and medium are provided for detecting anomalous payloads transmitted through a network. The system receives payloads within the network and determines a length for data contained in each payload. A statistical distribution is generated for data contained in each payload received within the network, and compared to a selected model distribution representative of normal payloads transmitted through the network. The model payload can be selected such that it has a predetermined length range that encompasses the length for data contained in the received payload. Anomalous payloads are then identified based on differences detected between the statistical distribution of received payloads and the model distribution. The system can also provide for automatic training and incremental updating of models
Patent CA-2546816-A1 (CA)
Inventor: HIEBERT TERRY
IPC: E05B15/00
Filed: 2006-05-15
Abstract: An auger latch for securing an auger assembly of a bulk loader, and having a mounting plate with a locking pin thereon for attachment to the loader. The latch features spaced apart guide plates, which define a longitudinally extending opening for receiving the locking pin.  A latch plate is pivotally secured to and positioned between the guide plates, the latch plate having a handle portion at one end thereof and a pin engaging portion at an opposite end. When the latch plate is in an unlocked position, the pin engaging portion extends into the opening defined by the guide plates.  When the auger assembly is to be moved from a working position to a stowed position adjacent a sidewall of the loader, the locking pin is inserted into the opening of the guide plates to initially engage the pin engaging portion, and, as the locking pin continues to be inserted into the opening, the pin engaging portion biasingly retracts, permitting the locking pin to be inserted fully into the opening. Once the locking pin has been inserted fully, the pin engaging portion extends to assume a locked position securing the pin in place within the opening. Spring means connected to the guide plates and the handle portion enable the latch plate to move from the locked position to an unlocked position, whereby the locking pin can be removed.
Patent CA-2549373-A1 (CA)
Inventor: HOWELL IAN
IPC: C11D3/22
Filed: 2004-12-01
Abstract: The Laundry composition of the invention contains a particulate brightener comprising a fluorescent whitening agent and a carrier in combination with a deposition aid, in order to deposit particulate brightener on to consumer articles during the wash.
Patent CA-2549493-A1 (CA)
Title: Device for analysing a body fluid
Inventor: SACHERER KLAUS-DIETER
IPC: G01N21/78
Filed: 2006-06-05
Abstract: The invention concerns a device for blood sugar tests comprising a test tape (12) which consists of a carrier tape (14) and a plurality of test fields (16) for the detection of an analyte in the body fluid and comprising a container (18) for the test tape (12) having a seal (24) for passage of the test tape (12) wherein the test fields (16) have a leading edge (32) which runs against a sealing edge (30) when the tape is pulled through. For a gentle tape passage it is proposed that the leading edge (32) or/and the sealing edge (30) at least in parts are angled or bent relative to the transverse direction of the tape.
Patent CA-2551410-A1 (CA)
Inventor: LO SHUN NAN
IPC: B05B1/14
Filed: 2006-06-30
Abstract: A water shutoff and discharge control device for sprinklers comprises a water intake assembly mounted to a support seat and swung back-and-forth by a sprinkling control assembly wherein the water intake assembly has a tube with multiple bores drilled thereon for the mounting of a sealing strip equipped with multiple spray nozzles and water-sealing areas. Both end sections of the tube are disposed multiple control channels each connecting to the interior of the tube for the extension of a control shaft with a plug mounted thereto. Each plug having an inlet aperture and an abutment surface is corresponded to a water-sealing area of the sealing strip to reveal a movement space there-between, permitting the plug flushed by the water flow to climb upwards and, depending on the movement of the control shaft, to switch in position relative to the spray nozzle for easy control of water shutoff or discharge thereby.
Patent CA-2552109-A1 (CA)
Inventor: MORINI EMILIO
IPC: B65D55/02
Filed: 2004-04-02
Abstract: The capsule (3) comprises a lower part (4) with a security strip (12) which is screwed on a neck (2) of the flagon (1) to be closed. The capsule also comprises a reservoir (8) inserted sealedly on the neck (2) of the flagon (1), the reservoir (8) being provided with a breakable bottom (8a); the lower part (4) of the capsule (3) being superiorly open in an outwards-facing direction and closed by an upper part (5) which is circumferentially connected to the lower part (4) by means of an easy-break ribbing (13).
Patent CA-2553021-A1 (CA)
Inventor: SUBRAHMANYA PARVATHANATHAN
IPC: H04W4/00
Filed: 2005-01-11
Abstract: A wireless communications network (120) responds to each incoming call placed to a wireless communications device (134) by transmitting a call-paging message (418) within a corresponding partition of a digital radio frame of prescribed format. Responsive to each occurrence of a broadcast event (404), the network transmits (414) a repeating broadcast-paging message announcing the availability of broadcast content from the network. The broadcast-paging message is transmitted multiple times within each digital radio frame. Another sequence (500) describes WCD operation in this network. Responsive to wakeup (502) from sleep, the WCD detects (509) received signal quality. The WCD also receives (510) scheduled network transmission of a call-paging message and a number of instances (at least one) of a repeating network transmitted broadcast-paging message that occurs multiple times for each scheduled transmission of the call-paging message. This number varies inversely with the detected signal quality.
Patent CA-2553937-A1 (CA)
Title: Adaptive closed group caricaturing
Inventor: SHADBOLT ADAM
IPC: G06T11/00
Filed: 2004-12-31
Abstract: A method and system for generating caricatured images of subjects wherein the caricatured image of each subject is adapted when subjects join and leave a closed group of which they are members. By adapting the caricatured images in this manner, it can be ensured that each caricatured image remains maximally distinguishable from the other images in the group, thus ensuring that recognition of the images may be maintained at a high level.
Patent CA-2554569-A1 (CA)
Inventor: ZAKI HASSAN
IPC: A23G1/48
Filed: 2005-02-02
Abstract: A soy-containing chocolate product having qualities akin to milk chocolate.  The chocolate product is prepared from a mixture of chocolate liquor, cocoa butter, a sweetener, and whole soybean powder. A method of making the chocolate product also is provided.
Patent CA-2556159-A1 (CA)
Inventor: VOHRA RAHUL
IPC: A61K31/513
Filed: 2005-02-11
Abstract: Disclosed are compositions which modulate the interaction of nerve growth factor and brain-derived neurotrophic factor with neurotrophic receptors, comprising contacting cells expressing a neurotrophin receptor with an effective amount of a compound of Formulas 1-6. Also disclosed are methods of using the compositions of the invention for the treatment of pain, inflammatory disorder and neurological disorder in subject in need.
Patent CA-2556424-A1 (CA)
Inventor: BARBERICH TIMOTHY
IPC: A61K31/343
Filed: 2005-02-17
Abstract: Methods for prophylaxis of or treating or preventing migraine or migraine headaches, or other headache disorders include administering to a subject in need of treatment a therapeutically effective amount of citalopram, escitalopram, or a racemic or optically pure citalopram metabolite, or pharmaceutically acceptable salts, solvates, polymorphs, or hydrates thereof.
Patent CA-2558995-A1 (CA)
Inventor: CHARRON CHARLES S
IPC: F16L19/08
Filed: 2006-09-08
Abstract: A coupling for joining to a conduit has a housing defining an interior chamber extending slang a longitudinal axis, and the housing has an open end for receiving a conduit in the chamber. The coupling further includes a plurality of circumferential locking teeth disposed in the housing and fixed against rotation about the longitudinal axis, the circumferential locking teeth having engagement ends adapted to engage an outer surface of a conduit upon receipt of the conduit in the chamber, to prevent rotation of the conduit relative to the coupling.
Patent CA-2559128-A1 (CA)
Inventor: HAMDOUCHI CHAFIQ HAMDOUCHI
IPC: C07D471/04
Filed: 2005-01-25
Abstract: The present invention provides kinase inhibitors of Formula I.
Patent CA-2559439-A1 (CA)
Title: Compositions for inhibiting or reducing inflammation of skin
Inventor: LIEBEL FRANK
IPC: A61P17/04
Filed: 2006-09-08
Abstract: The invention features a composition and methods for treating inflammation of skin, where the composition contains hydrocortisone and an avenanthramide.
Patent CA-2560335-A1 (CA)
Title: Micro coating comprising siloxanes
Inventor: KRUSE THOMAS
IPC: C09D7/48
Filed: 2005-03-21
Abstract: The invention relates to a binding agent comprising an aqueous, film-forming, polymeric siloxane. The invention also relates to a coating agent that is produced using said binding agent and to a workpiece that is coated with said coating agent.
Patent CA-2563610-A1 (CA)
Inventor: CURRIE SCOTT A
IPC: B60R3/00
Filed: 2006-10-12
Abstract: A vehicle step tube having a one-piece extruded body and a one-piece extruded step tread slidably interfitted together. The tube is fabricated of aluminum, and the step tread is fabricated of plastic or rubber. The step tread and the body are of substantially the same length so that the step tread provides a continues non-skid surface along the entire upper surface of the step tube.
Patent CA-2563926-A1 (CA)
Inventor: BREDESEN DALE E
IPC: G01N33/00
Filed: 2005-04-22
Abstract: In accordance with the present invention, it is demonstrated that selected mutations such as an Asp -> Ala (D664A) mutation in APP (which prevents cleavage at the caspase cleavage site) prevent both hippocampal synaptic loss and dentate gyral atrophy, even though such mutations do not interfere with the production of A~ or the formation of amyloid plaques in a transgenic model of Alzheimer's disease. Accordingly, in view of this finding, methods have been developed for the identification of agents which block cleavage at Asp664 of APP, including transgenic animals which are useful for such purpose, as well as methods for the use thereof for the treatment of neurodegenerative diseases.